Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation

Jin Hee Jung1, Jeong Ok Lee, Ji Hae Kim

  • 1Department of Anatomy, Korea University College of Medicine, Seongbuk-gu, Seoul 136-701, South Korea.

Insights

Quercetin, an antioxidant, combats HeLa cancer cells by activating AMP-activated protein kinase (AMPK) and down-regulating heat shock protein 70 (HSP70). This flavonoid also impacts epidermal growth factor receptor (EGFR) signaling, suggesting anti-tumor potential.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Quercetin, a plant flavonoid, exhibits antioxidant properties and potential chemopreventive effects against cancer.
  • The precise mechanisms underlying quercetin's anti-cancer activity remain incompletely elucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms by which quercetin exerts anti-tumor effects on HeLa cells.
  • To explore the roles of AMP-activated protein kinase (AMPK), heat shock protein 70 (HSP70), and epidermal growth factor receptor (EGFR) in quercetin's action.

Main Methods:

  • Cell viability assays were performed on HeLa cells treated with quercetin and AICAR (an AMPK activator).
  • Western blotting and knockdown experiments were used to assess protein phosphorylation, expression levels (AMPK, acetyl-CoA carboxylase, HSP70, caspase 3, EGFR, Cbl), and protein interactions.
  • Enzyme activity assays were conducted for caspase 3 and phosphatases (PP2a, SHP-2).

Main Results:

  • Quercetin treatment increased AMPK and acetyl-CoA carboxylase phosphorylation, suppressed HeLa cell viability, and reduced HSP70 levels.
  • Quercetin and AICAR elevated caspase 3 activity; AMPK knockdown abrogated quercetin-induced HSP70 downregulation, while HSP70 knockdown enhanced caspase 3 activation.
  • Quercetin sustained EGFR activation by inhibiting PP2a and SHP-2, increased EGFR-Cbl interaction, and induced Cbl tyrosine phosphorylation.

Conclusions:

  • Quercetin demonstrates anti-tumor effects on HeLa cells, mediated through the AMPK-HSP70 pathway.
  • Quercetin's modulation of EGFR signaling, including sustained activation and Cbl phosphorylation, contributes to its anti-cancer activity.